市場調查報告書
商品編碼
1029063

流式細胞技術的全球市場:產業趨勢,佔有率,規模,成長,機會,預測(2021年∼2026年)

Flow Cytometry Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日期: | 出版商: IMARC Services Private Limited | 英文 147 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球流式細胞技術的市場規模,預計從2015年到2020年顯示緩慢成長,2021年到2026年之間預計以8.2%的年複合成長率擴大。HIV-AIDS和癌症等慢性醫學疾病增加,是該市場的主要成長要素之一。再加上幹細胞治療的普及也促進著流式細胞技術的利用。

免疫表型,細胞分選,細胞生長化驗,細胞內鈣通量等,流式細胞技術的效用的認識高漲,也成為促進市場成長的大要素。還有流式細胞技術設備和人工智慧平台的整合等技術的進步和先進手法的登場對市場成長也有所貢獻。

本報告提供全球流式細胞技術市場的相關調查,市場成果,COVID-19的影響,各產品及服務、技術、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

第2章 範圍與調查手法

第3章 摘要整理

第4章 簡介

第5章 全球流式細胞技術市場

  • 市場概要
  • 市場成果
  • COVID-19的影響

第6章 各產品及服務的市場區隔

  • 設備
  • 試劑與消耗品
  • 配件
  • 軟體
  • 服務

第7章 各技術的市場區隔

  • 細胞為基礎的流式細胞技術
  • 以微珠為基礎的流式細胞技術

第8章 各用途的市場區隔

  • 腫瘤學
  • 藥物研發
  • 病的診斷
  • 幹細胞治療
  • 器官移植
  • 血液學
  • 其他

第9章 各終端用戶的市場區隔

  • 醫院、診療所
  • 學術、研究機關
  • 製藥、生物科技企業
  • 其他

第10章 各地區的市場區隔

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 各國市場區隔

第11章 SWOT分析

第12章 價值鏈分析

第13章 波特五力分析

第14章 競爭情形

  • 市場結構
  • 主要企業
  • 主要企業的簡介
    • Agilent Technologies Inc.
    • Apogee Flow Systems Ltd.
    • BD(Becton, Dickinson and Company)
    • Beckman Coulter Inc.(Danaher Corporation)
    • Bio-RAD Laboratories Inc.
    • Enzo Life Sciences Inc.
    • Luminex Corporation
    • Merck KGaA
    • Sony Biotechnology Inc.
    • Sysmex Partec GmbH
    • Thermo Fisher Scientific Inc.
目錄
Product Code: SR1020F13_Report

The global flow cytometry market exhibited moderate growth during 2015-2020. Flow cytometry refers to a biophysical and laser-based analytical technology that is used in the analysis of the cells or micelles that are usually suspended in a fluid using a laser beam. This technique aids in subclassifying cell types and detecting residual levels of disease through probes to develop the best treatment plan for the patient. Fluorescent probes, such as bisoxonol, can bind to proteins present on the cell membrane to facilitate the identification of various stages of cell injuries or necrosis. This technique also aids in understanding the structure and composition of the cells for chromosome analysis, cancer diagnosis, protein expression and diagnosis of diseases and hematological malignancies.

The increasing prevalence of chronic medical ailments, such as HIV-AIDS and cancer, is one of the key factors driving the growth of the market. The diagnosis of these diseases requires toxicity testing and an accurate, rapid and sensitive prognosis technique, which, in turn, is creating a positive outlook for the market growth. Furthermore, the widespread adoption of stem cell therapy is also enhancing the utilization of flow cytometry. Rising awareness regarding the benefits of this technique in immunophenotyping, cell sorting, cell proliferation assays and intracellular calcium flux is acting as another major growth-inducing factor. Additionally, several technological advancements, such as the integration of flow cytometry devices with artificial intelligence (AI) platforms, along with the advent of advanced methods, are also contributing to the market growth. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market further. Looking forward, IMARC Group expects the global flow cytometry market to grow at a CAGR of 8.2% during 2021-2026.

Breakup by Product and Service:

  • Instruments
  • Reagents and Consumables
  • Accessories
  • Software
  • Services

Breakup by Technology:

  • Cell-Based Flow Cytometry
  • Bead-Based Flow Cytometry

Breakup by Application:

  • Oncology
  • Drug Discovery
  • Disease Diagnosis
  • Stem Cell Therapy
  • Organ Transplantation
  • Hematology
  • Others

Breakup by End-User:

  • Hospitals and Clinics
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Apogee Flow Systems Ltd., BD (Becton, Dickinson and Company), Beckman Coulter Inc. (Danaher Corporation), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc., Luminex Corporation, Merck KGaA, Sony Biotechnology Inc., Sysmex Partec GmbH, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global flow cytometry market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global flow cytometry market?
  • What is the breakup of the market based on the product and service?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global flow cytometry market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Flow Cytometry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Accessories
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Software
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Services
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Cell-Based Flow Cytometry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bead-Based Flow Cytometry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Discovery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Disease Diagnosis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Stem Cell Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Organ Transplantation
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Hematology
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Apogee Flow Systems Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BD (Becton, Dickinson and Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Bio-RAD Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Enzo Life Sciences Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Luminex Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sony Biotechnology Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sysmex Partec GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Flow Cytometry Market: Major Drivers and Challenges
  • Figure 2: Global: Flow Cytometry Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Flow Cytometry Market: Breakup by Product and Service (in %), 2020
  • Figure 4: Global: Flow Cytometry Market: Breakup by Technology (in %), 2020
  • Figure 5: Global: Flow Cytometry Market: Breakup by Application (in %), 2020
  • Figure 6: Global: Flow Cytometry Market: Breakup by End-User (in %), 2020
  • Figure 7: Global: Flow Cytometry Market: Breakup by Region (in %), 2020
  • Figure 8: Global: Flow Cytometry Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 9: Global: Flow Cytometry (Instruments) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 10: Global: Flow Cytometry (Instruments) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 11: Global: Flow Cytometry (Reagents and Consumables) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 12: Global: Flow Cytometry (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 13: Global: Flow Cytometry (Accessories) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 14: Global: Flow Cytometry (Accessories) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 15: Global: Flow Cytometry (Software) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 16: Global: Flow Cytometry (Software) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 17: Global: Flow Cytometry (Services) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 18: Global: Flow Cytometry (Services) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 19: Global: Flow Cytometry (Cell-Based Flow Cytometry) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 20: Global: Flow Cytometry (Cell-Based Flow Cytometry) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 21: Global: Flow Cytometry (Bead-Based Flow Cytometry) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 22: Global: Flow Cytometry (Bead-Based Flow Cytometry) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 23: Global: Flow Cytometry (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 24: Global: Flow Cytometry (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 25: Global: Flow Cytometry (Drug Discovery) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 26: Global: Flow Cytometry (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 27: Global: Flow Cytometry (Disease Diagnosis) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 28: Global: Flow Cytometry (Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 29: Global: Flow Cytometry (Stem Cell Therapy) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 30: Global: Flow Cytometry (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 31: Global: Flow Cytometry (Organ Transplantation) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 32: Global: Flow Cytometry (Organ Transplantation) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: Global: Flow Cytometry (Hematology) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: Global: Flow Cytometry (Hematology) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Global: Flow Cytometry (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Global: Flow Cytometry (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: Global: Flow Cytometry (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: Global: Flow Cytometry (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 39: Global: Flow Cytometry (Academic and Research Institutes) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 40: Global: Flow Cytometry (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 41: Global: Flow Cytometry (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 42: Global: Flow Cytometry (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 43: Global: Flow Cytometry (Other End-Users) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 44: Global: Flow Cytometry (Other End-Users) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 45: North America: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 46: North America: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 47: United States: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 48: United States: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 49: Canada: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 50: Canada: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 51: Asia Pacific: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 52: Asia Pacific: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 53: China: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 54: China: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 55: Japan: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 56: Japan: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 57: India: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 58: India: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 59: South Korea: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 60: South Korea: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 61: Australia: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 62: Australia: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 63: Indonesia: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 64: Indonesia: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 65: Others: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 66: Others: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 67: Europe: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 68: Europe: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 69: Germany: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 70: Germany: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 71: France: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 72: France: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 73: United Kingdom: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 74: United Kingdom: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 75: Italy: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 76: Italy: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 77: Spain: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 78: Spain: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 79: Russia: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 80: Russia: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 81: Others: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 82: Others: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 83: Latin America: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 84: Latin America: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 85: Brazil: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 86: Brazil: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 87: Mexico: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 88: Mexico: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 89: Others: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 90: Others: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 91: Middle East and Africa: Flow Cytometry Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 92: Middle East and Africa: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 93: Global: Flow Cytometry Industry: SWOT Analysis
  • Figure 94: Global: Flow Cytometry Industry: Value Chain Analysis
  • Figure 95: Global: Flow Cytometry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Flow Cytometry Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Flow Cytometry Market Forecast: Breakup by Product and Service (in Million US$), 2021-2026
  • Table 3: Global: Flow Cytometry Market Forecast: Breakup by Technology (in Million US$), 2021-2026
  • Table 4: Global: Flow Cytometry Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 5: Global: Flow Cytometry Market Forecast: Breakup by End-User (in Million US$), 2021-2026
  • Table 6: Global: Flow Cytometry Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 7: Global: Flow Cytometry Market: Competitive Structure
  • Table 8: Global: Flow Cytometry Market: Key Players